Clinical trial

A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing

NCT00381173

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-11-01

PhasePHASE1

Study timeline

Study start (unknown)2006-11-01Date precision: month

Registry last updated2013-05-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Ovarian Cancerunresolved

Prostate Cancerunresolved

Colon Cancerunresolved

Renal Cancerunresolved

Interventions

Cyclophosphamide & ZYC300 (ZYC300 with cyclophosphamide pre-dosing)DRUG

Sponsors & collaborators

Eisai Inc.lead sponsor

Mapped research locations

HoustonTexas, United States1 BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00381173 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.